Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
63.50    0.00 (0.00%)
Bid:
62.00
Ask:
65.00
Spread: 3.00 (4.839%)
Market Cap: £104.20m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Board Update and Directorate Changes

13 May 2020 07:00

RNS Number : 6974M
Distribution Finance Cap. Hldgs PLC
13 May 2020
 

13 May 2020

Distribution Finance Capital Holdings plc ("DFC" or the "Company" or together with its subsidiaries the "DFC Group")

Board Update and Directorate Changes

The Company has relationship agreements in place with its two largest shareholders, Arrowgrass Master Fund Limited (AMFL) and Watrium AS. In line with market practice for such agreements, and as described in the Company's AIM Admission Document, both shareholders are entitled to appoint representative directors to the Board for as long as their shareholdings exceed agreed percentage thresholds.

As envisaged by these relationship agreements, both AMFL and Watrium AS recently informed the Company that they wished to appoint representative directors. The Board is therefore pleased to announce the appointment of Mr Stephen Greene (on behalf of AMFL) and Mr Haakon Stenrod (on behalf of Watrium AS) as Non-Executive Directors, with effect from today.

Mr Greene has investment banking, investing and capital markets experience, previously holding positions at Keel Harbour Capital Limited, Arrowgrass Capital Partners, RMG Wealth Management, ACPI Investments and Deutsche Bank. Recently he has transitioned into more technology focused roles, specifically within financial services and artificial intelligence, and currently serves as Managing Director of Orsus Ventures Limited and Coleura Labs Limited and formerly served as Managing Director of Satalia. Mr Greene has a Money, Banking and Finance degree from the University of Birmingham and is a Chartered Financial Analyst (CFA) charterholder.

Mr Stenrod is an Investment Director at Watrium AS. He was previously a partner with the leading Nordic investment banking group ABG Sundal Collier. He has broad transaction experience in M&A, equity capital markets, debt and restructuring advisory. He holds an M.Sc. in Industrial Economics and Technology Management from the Norwegian University of Science and Technology.

The Company also announces that Henry Kenner and James van den Bergh will be stepping down from the Board with immediate effect. Henry has been involved with DFC since its inception and has played an important part in the execution of the Company's strategy during that time. Alongside Henry, James joined the Board of DFC as a non-executive Director in the run-up to IPO in May 2019 to assist the Company as it transitioned from being a subsidiary of TruFin PLC to an independent company admitted to AIM. Henry is Chairman and James is CEO of TruFin plc and both remain shareholders of DFC.

Chairman John Baines commented:

"The entire firm is grateful to Henry and James for their support and advocacy of DF Capital. Without their enthusiasm and belief in the founders' vision much of what has been achieved by the company would not have been possible. Both have proven exceptional board colleagues and their wise counsel and experience has been valued by the entire board. Specifically, in relation to Henry, we appreciate him stepping in as Interim CEO last year and ensuring strategic momentum was not lost whilst we recruited a new permanent CEO and continued to progress the banking licence application. We wish both Henry and James well in their other commercial engagements beyond DFC.

The Board is delighted to welcome Stephen and Haakon as Non-Executive Directors and looks forward to working with them in supporting DFC's strategic ambitions."

Additional information required to be disclosed under Schedule Two of the AIM Rules:

Mr Greene, aged 43, currently holds or has held the following directorships and partnerships over the last five years:

Current:

Past:

Trufin plc.

Keel Harbour

Orsus Ventures Limited

Capital Limited

Coleura Labs Limited

Mr Greene currently has no shares in the Company in a personal capacity. AMFL owns 52,448,082 shares or 49.2% of the Company.

Mr Stenrod, aged 39, has no directorships and partnerships over the last five years to disclose under Schedule Two of the AIM Rules and currently has no shares in the Company in a personal capacity. His employer, Watrium AS, owns 14,833,922 shares or 13.9% of the Company.

Except as disclosed in this announcement, no other disclosures are required in respect of the appointment of Mr Greene or Mr Stenrod under paragraph (g) of Schedule Two of the AIM Rules for Companies.

For further information, please contact:

Enquiries:

 

Distribution Finance Capital Holdings plc

Carl D'Ammassa - Chief Executive Officer +44 (0) 20 3937 6390

http://www.dfcapital-investors.com

Macquarie Capital (Europe) Limited (NOMAD and broker)

Alex Reynolds +44 (0) 20 3037 2000

Jonny Allison

Blue Pool Communications (Financial PR)

Nick Lord +44 (0) 7501 271 083

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABCGDUGXBDGGD
Date   Source Headline
12th Oct 202211:37 amRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSThird Quarter Loan Book
30th Sep 20223:23 pmRNSDirector/PDMR Shareholding
30th Sep 20223:02 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSHalf-year Report
13th Sep 20229:15 amRNSNotice of Results
3rd Aug 202210:53 amRNSHolding(s) in Company
11th Jul 20227:00 amRNSQ2 Trading Update
15th Jun 202212:52 pmRNSResult of AGM
9th Jun 20224:45 pmRNSDirector/PDMR Shareholding
24th May 202210:23 amRNSNotice of AGM
12th May 20223:45 pmRNSDirector/PDMR Shareholding
12th May 20222:40 pmRNSDirector/PDMR Shareholding
12th May 20229:04 amRNSDirector/PDMR Shareholding
9th May 20223:11 pmRNSDirector/PDMR Shareholding
4th May 20227:00 amRNSDirectorate Change
13th Apr 20227:00 amRNSFinal Results
4th Apr 20227:00 amRNSQ1 Trading Update
16th Mar 20229:30 amRNSHolding(s) in Company
16th Mar 20229:30 amRNSHolding(s) in Company
16th Mar 20229:30 amRNSHolding(s) in Company
23rd Feb 20225:13 pmRNSHolding(s) in Company
21st Feb 20224:31 pmRNSHolding(s) in Company
9th Feb 20227:00 amRNSAppointment of Independent Non-Executive Chair
26th Jan 20229:35 amRNSHolding(s) in Company
18th Jan 20228:19 amRNSProgressive publishes new research
18th Jan 20227:00 amRNSTrading Update
14th Dec 20215:03 pmRNSHolding(s) in Company
14th Dec 20214:58 pmRNSHolding(s) in Company
14th Dec 202110:02 amRNSHolding(s) in Company
13th Dec 20213:27 pmRNSHolding(s) in Company
13th Dec 202112:22 pmRNSHolding(s) in Company
10th Dec 20214:42 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20213:05 pmRNSDirector/PDMR Shareholding
10th Dec 202112:17 pmRNSHolding(s) in Company
10th Dec 202111:16 amRNSDirectorate Change
10th Dec 20217:00 amRNSResult of Secondary Placing
9th Dec 20214:51 pmRNSProposed Secondary Placing
7th Dec 20217:47 amRNSProgressive publishes new research
6th Dec 20217:00 amRNSTrading Update
5th Oct 20217:00 amRNSThird Quarter Loan Book
23rd Sep 20217:32 amRNSProgressive publishes new research
23rd Sep 20217:00 amRNSHalf-year Report
13th Sep 20214:48 pmRNSHolding(s) in Company
3rd Sep 20214:28 pmRNSHolding(s) in Company
9th Jul 20217:51 amRNSProgressive publishes new research
2nd Jul 20217:00 amRNSQ2 Trading Update
19th May 20212:12 pmRNSResult of AGM
19th May 202111:48 amRNSDirectorate Change and Withdrawal of Resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.